Report overview
A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.
This report aims to provide a comprehensive presentation of the global market for Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptic Ulcer Drugs. This report contains market size and forecasts of Peptic Ulcer Drugs in global, including the following market information:
Global Peptic Ulcer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Peptic Ulcer Drugs Market Sales, 2018-2023, 2024-2029, (M Unit)
Global top five Peptic Ulcer Drugs companies in 2022 (%)
The global Peptic Ulcer Drugs market was valued at US$ 17980 million in 2022 and is projected to reach US$ 23080 million by 2029, at a CAGR of 3.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main global Peptic Ulcer Drugs players include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, etc. The top five Peptic Ulcer Drugs players account for approximately 43% of the total market. United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%. And in terms of application, the largest application is Hospital and Clinic, followed by Drugstore.
We surveyed the Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptic Ulcer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Unit)
Global Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors
H2-Antagonists
Antacids
Others
Global Peptic Ulcer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Unit)
Global Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital and Clinic
Drugstore
Global Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Unit)
Global Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptic Ulcer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Key companies Peptic Ulcer Drugs sales in global market, 2018-2023 (Estimated), (M Unit)
Key companies Peptic Ulcer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceutical
AstraZeneca
Pfizer
Teva Pharmaceuticals
EA Pharma
ASK Pharm
Luoxin Pharmaceutical
Abbott Laboratories
Yuhan Pharmaceutical
Daewoong Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptic Ulcer Drugs, market overview.
Chapter 2: Global Peptic Ulcer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Peptic Ulcer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptic Ulcer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
